Navigation Links
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
Date:11/5/2009

hapes in both men and women. Each year in the United States alone, there are over 750,000 new cases of ano-genital warts. Treatment options today are limited by tolerability issues such as pain, irritation and swelling at the treatment site. Treatments may include topical preparations, intralesional injection of interferon Alpha-2b and surgically ablative procedures. Helix believes that more effective and better tolerated treatments are needed.

About Topical Interferon Alpha-2b

Interferon Alpha-2b is an immune system modulator that is active against a variety of HPV-induced lesions. Interferon Alpha-2b is thought to function by triggering an antiviral response within infected cells, by activating certain intracellular enzymes which cause degradation of viral RNA, and by mobilizing the body's natural immune system to destroy the infected cells. Interferon Alpha-2b has been widely used commercially as a treatment for ano-genital warts caused by HPV, but is not generally favored due to the fact that conventional administration requires painful intralesional injection by a medical professional. Furthermore, intralesional injection is restricted to visible lesion administration, while HPV infection is often characterized by both visible and non-visible (i.e. sub-clinical) lesions. Helix's Topical Interferon Alpha-2b utilizes the Company's proprietary Biphasix(TM) drug delivery technology, and is expected to offer a safe, discreet, self-administered, pain-free therapy that can be broadly applied across the entire affected tissue area. Helix anticipates that this will prove highly advantageous not only from a patient compliance perspective by offering a superior tolerability profile, but also from an efficacy standpoint.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prev
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Helix BioPharma Corp. Announces Fiscal 2009 Results
2. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
3. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
4. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
5. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
6. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
10. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
11. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Ill. , April 17, 2015  AbbVie Inc. ("AbbVie") ... announced that it has extended the expiration of its exchange ... stock of Pharmacyclics, Inc. to 5 p.m., New ... On April 17, 2015, AbbVie also voluntarily withdrew ... Improvements Act in order to provide the FTC with additional ...
(Date:4/17/2015)... 2015 Inivata, a Cambridge, ... their presence at the 2015 American Association for Cancer Research ... Nitzan Rosenfeld and a poster presentation. Michael ... - 22 nd . The presentation, entitled ... , forms part of a session on Recent ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Equipment Rental and Leasing - Global Strategic Business ... report analyzes the worldwide markets for Medical Equipment Rental ... comprehensive analytics for the US, Japan ... World. Annual estimates and forecasts are provided ...
Breaking Medicine Technology:AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2
... UCB offers Cimzia(R) (certolizumab pegol), a treatment option ... arthritis and moderate to severe Crohn,s disease, to ... resulting from the UCB partnership with OXO(R) ... and OXO(R) in the development of the new ...
... Results Show Superior Decrease in Pain Scores Compared to ... presented the results of a six-month safety and efficacy ... at decreasing the pain of knee osteoarthritis (OA) at ... is superior to saline in decreasing pain at 26 ...
Cached Medicine Technology:Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 2Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 3Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 4Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 5Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 6Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 7Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 8Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 9Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 10Video: Partnership Unites UCB with Consumer Product Innovator OXO(R) 11Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 2Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 3
(Date:4/19/2015)... The American Association for Physician Leadership® ... the inaugural winner of the Roger Schenke Award. The ... 18, in Las Vegas, Nevada. , Ellner, president ... the department of surgery and director of surgical quality ... Connecticut, was instrumental in the founding of the Connecticut ...
(Date:4/19/2015)... Lowcostcarinsuranceprice.com has released a new ... get drivers arrested for DUI. The blog post also ... premiums . , Some pills can have dangerous ... Drivers who are under medication should ask their doctor’s ... pills can be considered driving under the influence and ...
(Date:4/19/2015)... York (PRWEB) April 19, 2015 New ... Multidistrict Litigation (JPML) indicate that Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... in U.S. District Court, District of South Carolina. According ... cases have been filed in the proceeding on behalf ... to their use of the cholesterol-lowering statin. This represents ...
(Date:4/19/2015)... 2015 McCann Investigations, a Texas-based full ... publication of white paper Married, but Dating: The ... online media provides a unique environment of privacy, anonymity ... targeting adulterous spouses has emerged. Social platforms which ... easy as shopping online. Dating sites and mobile ...
(Date:4/19/2015)... Wisconsin Dells, WI (PRWEB) April 19, 2015 ... solutions designer announces that it will exhibit it’s ... Conference and Expo and the Iowa-Illinois Safety Council Professional ... Go 6350 and the TaskMate EZ are used in ... and healthcare facilities. , Built to clamp to ...
Breaking Medicine News(10 mins):Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Driving On Medication - Possible Effects On Auto Insurance Prices 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2
... , , , ... a major expansion to its product offering with the ... (MAPS) and the integration of the ClearPoint Security Performance ... solution - The ClearPoint Unified Security Performance and Compliance ...
... , , ... Oz Show," a high octane, multi-topic hour-long series hosted by trusted ... premieres in syndication today (check local listings). Episodes airing ... Team Oz" guest contributors, fashion and style expert Tim Gunn ("Project ...
... , MealsMatter.org Offers Delicious Ways to Keep the ... Sept. 14 As flu season grips the nation with heightened awareness ... method getting left out in the cold. , , ... groups throughout the year, but it,s particularly significant during flu season," said ...
... ... the results of the largest study ever performed of tubal reversal surgery, ... is more successful than IVF for couples wanting more children after a ... of the tubal reversal patients had reported pregnancies. "A simple one-hour outpatient ...
... , , , PITTSBURGH, Sept. ... Inc. is prototyping an innovative stroke treatment device designed to speed ... , , Michele Migliuolo, NeuroInterventions President ... a presentation at the 3 Rivers Venture Fair in Pittsburgh on ...
... works in different way than standard medicines , SUNDAY, ... people whose high blood pressure cannot be controlled by ... researchers report. , Substantial reductions in blood pressure were ... people who were still hypertensive despite trying three or ...
Cached Medicine News:Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 2Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 3Health News:ClearPoint Announces Metric Applications Packages for PCI DSS, NERC, Healthcare Compliance and FISMA 4Health News:'The Dr. Oz Show' Premieres Today Nationwide 2Health News:'The Dr. Oz Show' Premieres Today Nationwide 3Health News:'The Dr. Oz Show' Premieres Today Nationwide 4Health News:'The Dr. Oz Show' Premieres Today Nationwide 5Health News:Protect Your Family With Flu-Fighting Foods 2Health News:Study Shows Tubal Reversal Surgery is the Best Treatment to Have More Children After a Tubal Ligation 2Health News:Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke 2Health News:Drug Offers Hope Against Tough-to-Treat Hypertension 2Health News:Drug Offers Hope Against Tough-to-Treat Hypertension 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: